Missed Opportunities in the Trial on Proton-Pump Inhibitor Therapy in Bleeding Peptic Ulcers
- Vivian Yih, BSc(Pharm); and
- Aaron Tejani, BSc(Pharm), PharmD
- From Fraser Health, Surrey, British Columbia V3R 7P8, Canada.
TO THE EDITOR:
In their article on prevention of recurrent ulcer bleeding, Sung and colleagues (1) conclude that theirs is the first international trial supporting the efficacy of high-dose intravenous proton-pump inhibitor (PPI) therapy in white patients with acute peptic ulcer bleeding. We have several concerns with this statement. First, Sung and colleagues' initial intent was to study a multiethnic population, which would have been enlightening …
RSS Feeds









